These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 16938519)
1. The close relationship between heparanase and cyclooxygenase-2 expressions in signet-ring cell carcinoma of the stomach. Ohtawa Y; Naomoto Y; Shirakawa Y; Takaoka M; Murata T; Sonoda R; Sakurama K; Yamatsuji T; Gunduz M; Tsujigiwa H; Nagatsuka H; Terada N; Itano S; Horiki S; Yanagihara K; Nakajima M; Tanaka N Hum Pathol; 2006 Sep; 37(9):1145-52. PubMed ID: 16938519 [TBL] [Abstract][Full Text] [Related]
2. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Okawa T; Naomoto Y; Nobuhisa T; Takaoka M; Motoki T; Shirakawa Y; Yamatsuji T; Inoue H; Ouchida M; Gunduz M; Nakajima M; Tanaka N Clin Cancer Res; 2005 Nov; 11(22):7995-8005. PubMed ID: 16299228 [TBL] [Abstract][Full Text] [Related]
3. [Relation of heparanase mRNA expression and angiogenesis to the progression of gastric carcinoma]. Ren XL; Zhu RZ; Wang LJ; Zhang ML; Li DH; Deng XQ Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):368-71. PubMed ID: 12921569 [TBL] [Abstract][Full Text] [Related]
4. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of signet ring cell carcinoma of the stomach. Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148 [TBL] [Abstract][Full Text] [Related]
6. Heparanase gene expression and metastatic potential in human gastric cancer. Endo K; Maejara U; Baba H; Tokunaga E; Koga T; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Nakajima M; Sugimachi K Anticancer Res; 2001; 21(5):3365-9. PubMed ID: 11848495 [TBL] [Abstract][Full Text] [Related]
7. [Increased expression of heparanase mRNA is correlated with metastasis of gastric carcinoma and is probably correlated with c-met protein]. Cai YG; Fang DC; Yang SM; Luo YH; Yang MH; Wang DX Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):974-8. PubMed ID: 15312528 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613 [TBL] [Abstract][Full Text] [Related]
9. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis. Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632 [TBL] [Abstract][Full Text] [Related]
10. [mRNA expression of syndecan-1 and heparanase in relation to tumor progression and prognosis of gastric carcinoma]. Ru GQ; Zhao ZS; Tang QL; Xu WJ Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1062-4. PubMed ID: 17074248 [TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of early growth response 1 in gastric cancer: association with tumor invasion, metastasis and heparanase transcription. Zheng L; Pu J; Jiang G; Weng M; He J; Mei H; Hou X; Tong Q Pathol Int; 2010 Apr; 60(4):268-77. PubMed ID: 20403028 [TBL] [Abstract][Full Text] [Related]
12. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis. Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740 [TBL] [Abstract][Full Text] [Related]
14. [Association of abnormal cyclooxygenase-2 gene expression with colorectal carcinoma metastasis]. Li ZG; Liu TF; Xie WB; Zhou J; Yu L; Ding YQ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1408-11. PubMed ID: 17062337 [TBL] [Abstract][Full Text] [Related]
15. Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Tang W; Nakamura Y; Tsujimoto M; Sato M; Wang X; Kurozumi K; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Mod Pathol; 2002 Jun; 15(6):593-8. PubMed ID: 12065771 [TBL] [Abstract][Full Text] [Related]
16. [Relationship between heparanase mRNA expression in human gastric cancer and its clinicopathological features]. Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Chen ZX; Huang YH; Cai SR Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):609-11. PubMed ID: 15634522 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with lymph node metastasis. Peng JP; Chang HC; Hwang CF; Hung WC Oral Oncol; 2005 Oct; 41(9):903-8. PubMed ID: 16054423 [TBL] [Abstract][Full Text] [Related]
18. Advanced gastric carcinoma with signet ring cell histology. Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078 [TBL] [Abstract][Full Text] [Related]
19. Detection of peritoneal micrometastasis by reverse transcriptase-polymerase chain reaction for heparanase mRNA and cytology in peritoneal wash samples. Wang Z; Zhang X; Xu H; Zhou X; Jiang L; Lu C J Surg Oncol; 2005 May; 90(2):59-65. PubMed ID: 15844185 [TBL] [Abstract][Full Text] [Related]
20. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis. Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]